Reduction of eNOS expression and decreased NO levels in platelets from HD patients, could virtually reflect central defects and potentially clarify the molecular basis of cerebral hypoperfusion previously described in HD patients [34]. This evidence concerns the gene NOS3 and Huntington disease.